Cabozantinib Impurity 36 | CAS 10197-51-0 - Request Quote
Cabozantinib Impurity 36
| SZ CAT No: | SZ-C112052 |
| CAS No | 10197-51-0 |
| Mol.F. | C14H10F2N2O2 |
| Mol.Wt. | 276.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib Impurity 36 is chemically N1,N2-Bis(4-fluorophenyl)oxalamide. Cabozantinib Impurity 36 is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib Impurity 36 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 10197-51-0
Purchase 10197-51-0
Order 10197-51-0
Enquire 10197-51-0
price of 10197-51-0
10197-51-0 Supplier
10197-51-0 Manufacturer
10197-51-0 Exporter
buy high quality Cabozantinib Impurity 36
Purchase Cabozantinib Impurity 36
Cabozantinib Impurity 36 suppliers
Cabozantinib Impurity 36 manufacturers
Cabozantinib Impurity 36 price
Order Cabozantinib Impurity 36
Enquire Cabozantinib Impurity 36
Cabozantinib Impurity 36 cost
Cabozantinib Impurity 36 Supplier
Cabozantinib Impurity 36 Distributor
Cabozantinib Impurity 36 for Method Validation
Cabozantinib Reference Standard
Cabozantinib Impurity 36 for ANDA Filing
Cabozantinib Impurity 36 for Forced Degradation Studies
Cabozantinib Impurity 36 Identification Standards
Cabozantinib Impurity 36 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


